
Teva reports negative data from LEGATO-HD trial
Teva Pharmaceutical Industries has reported negative outputs from the LEGATO-HD trial after it failed to meet the primary endpoint.
Teva Pharmaceutical Industries has reported negative outputs from the LEGATO-HD trial after it failed to meet the primary endpoint.
Thank you for subscribing to Clinical Trials Arena